TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/22/21 21:42 | 10/20/21 | FDMT | 4D Molecular Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schaffer David | CA | D | S.m | -1,138 | 31.36 | 0 | -36 | -4 | 901 | D | |||||||||||||||
10/1/21 16:34 | 9/29/21 | FDMT | 4D Molecular Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schaffer David | CA | D | S.m | -816 | 27.89 | 0 | -29 | -3 | 938 | D | |||||||||||||||
9/29/21 16:05 | 9/27/21 | FDMT | 4D Molecular Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schaffer David | CA | D | S.m | -1,061 | 31.90 | 0 | -33 | -3 | 967 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |